Comparison of Maxillary Dental Expansion Using Smartee Clear Aligner With and Without S11 Expander: A Randomized Clinical Trial
RCT expansion
2 other identifiers
interventional
30
1 country
1
Brief Summary
To compare the effects of Smartee S11 expander with conventional clear aligner expansion using cone beam computed tomography (CBCT). The secondary objective is to evaluate the degree of orthodontic expansion and the type of tooth movement achieved with Smartee aligners on the maxillary arch.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 10, 2026
CompletedFirst Posted
Study publicly available on registry
April 16, 2026
CompletedStudy Start
First participant enrolled
May 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 20, 2027
April 16, 2026
April 1, 2026
7 months
April 10, 2026
April 10, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
comparison the effect of S11 expander with conventional one
To compare the effects of Smartee S11 expander with conventional clear aligner expansion using cone beam computed tomography (CBCT).
from the enrollment to the end of expansion at 6 months
Study Arms (2)
group 1
ACTIVE COMPARATORwith conventional expander
group 2
EXPERIMENTALwith S11 expander
Interventions
new feature incorporated into the aligners, called trans Palatal bar (S11-Horizontal Arch Expander) which is an invisible clear trans Palatal expander customized to the patient through digital design and individual cutting
Eligibility Criteria
You may qualify if:
- healthy cooperative female and male patients who will undergo maxillary expansion with Smartee aligners, A young adult/adult patients starting from age of 18 up to 35 years old.
- patients with maxillary compression of non-skeletal origin, moderate dental crowding in the upper arch (4-8mm). 3- patients with unilateral or bilateral crossbite, patients will be treated with intermaxillary elastics without distalization or mesialization of the dental arches.
- patients with sufficient clinical crown height (greater than 4 mm), no mesial rotation of the upper first molar. 5- there is good compliance during the treatment (wearing aligners for 20 hours per day).
- good quality x-rays with appropriate visualization of landmarks and control of head rotation. 7- absence of periodontal disease, and absence of previous prosthodontic treatments of the upper molars.
You may not qualify if:
- signs and/or symptoms of temporomandibular abnormalities (TMDs). 2- active periodontal disease. 3- prosthodontic rehabilitations of the maxillary molar or ankylosed teeth, and endodontic treatments of the maxillary molars. 4- patients requiring orthognathic surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Private Clinic
Jeddah, Saudi Arabia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
ali habib habib, professor
King Abdulaziz University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- postgraduate student
Study Record Dates
First Submitted
April 10, 2026
First Posted
April 16, 2026
Study Start
May 14, 2026
Primary Completion (Estimated)
December 20, 2026
Study Completion (Estimated)
May 20, 2027
Last Updated
April 16, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
The dataset contains sensitive patient information, and sharing it could compromise participant confidentiality despite de-identification efforts. Access to the data is therefore restricted in accordance with institutional review board (IRB) guidelines.